Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Revogene

K-Number: K222779 · 2023-01-26

Decision Date2023-01-26
Product CodeOOI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Revogene is a medical device manufactured by Meridian Bioscience, Inc.. It received FDA 510(k) clearance on 2023-01-26 under approval number K222779. The device is classified under product code OOI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Revogene?

Revogene is a medical device that received FDA 510(k) clearance on 2023-01-26. It is manufactured by Meridian Bioscience, Inc.. The 510(k) number is K222779.

When was Revogene approved by the FDA?

Revogene received FDA 510(k) clearance on 2023-01-26, under approval number K222779.

What company makes Revogene?

Revogene is manufactured by Meridian Bioscience, Inc..

What is the FDA product code for Revogene?

The FDA product code for Revogene is OOI.

Other Devices by Meridian Bioscience, Inc.

View all 13 devices →

Related Devices (Code: OOI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.